Wealth Enhancement Advisory Services, LLC Erasca, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 28,139 shares of ERAS stock, worth $40,801. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,139Holding current value
$40,801% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ERAS
# of Institutions
156Shares Held
227MCall Options Held
10.9KPut Options Held
65.1K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$28.1 Million2.92% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.7MShares$24.2 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$23.5 Million6.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$18.4 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA12.5MShares$18.1 Million4.12% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $177M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...